drugset / Trial / NCT04916197

Effect of Postoperative Prolonged Sedation With Dexmedetomidine After Successful Reperfusion With EVT on Long-term Prognosis in Patients With AIS (PPDET)

NCT04916197 ↗

Phase 4 Recruiting 368 enrolled Beijing Chao Yang Hospital
RandomizedParallel-groupOpen-labelPrevention

Summary

Dexmedetomidine can attenuate the activity of the sympathetic nervous system under stress response and improve ischemia-reperfusion injury. The investigators hypothesized that the prolonged sedation of dexmedetomidine after successful reperfusion of endovascular thrombectomy may improve the clinical outcome of acute ischemic stroke patients.

Timeline

Start
2024-03-01
Primary completion
2026-12
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.1 ug/kg —
Subject Dexmedetomidine Other / unclassified 1 ug/kg —

Indications